Alpha Dna Investment Management LLC Dynavax Technologies Corp Transaction History

Alpha Dna Investment Management LLC

  • $261 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$12.64 - $14.99 $507,293 - $601,608
40,134 New
40,134 $592,000
Q1 2022

May 13, 2022
SELL
$9.75 - $14.44 $1.03 Million - $1.53 Million
-105,910 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$13.17 - $20.94 $1.39 Million - $2.22 Million
105,910 New
105,910 $1.49 Million

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email